Literature DB >> 28695657

HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry.

E K K Henriksen1,2,3,4, M K Viken3,5, M Wittig6, K Holm1,2,3,4, T Folseraas1,2,3,4,7, S Mucha6, E Melum1,2,3,7, J R Hov1,2,3,4,7, K N Lazaridis8, B D Juran8, O Chazouillères9, M Färkkilä10, D N Gotthardt11, P Invernizzi12, M Carbone12, G M Hirschfield13, S M Rushbrook14, E Goode15, C Y Ponsioen16, R K Weersma17, B Eksteen18, K K Yimam19, S C Gordon20, D Goldberg21, L Yu22, C L Bowlus23, A Franke6, B A Lie3,5,24, T H Karlsen1,2,3,4,7.   

Abstract

Primary sclerosing cholangitis (PSC) is strongly associated with several human leukocyte antigen (HLA) haplotypes. Due to extensive linkage disequilibrium and multiple polymorphic candidate genes in the HLA complex, identifying the alleles responsible for these associations has proven difficult. We aimed to evaluate whether studying populations of admixed or non-European descent could help in defining the causative HLA alleles. When assessing haplotypes carrying HLA-DRB1*13:01 (hypothesized to specifically increase the susceptibility to chronic cholangitis), we observed that every haplotype in the Scandinavian PSC population carried HLA-DQB1*06:03. In contrast, only 65% of HLA-DRB1*13:01 haplotypes in an admixed/non-European PSC population carried this allele, suggesting that further assessments of the PSC-associated haplotype HLA-DRB1*13:01-DQA1*01:03-DQB1*06:03 in admixed or multi-ethnic populations could aid in identifying the causative allele.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990PSC; causative; human leukocyte antigen; multi-ethnic; trans-ancestry

Mesh:

Substances:

Year:  2017        PMID: 28695657      PMCID: PMC7359736          DOI: 10.1111/tan.13076

Source DB:  PubMed          Journal:  HLA        ISSN: 2059-2302            Impact factor:   4.513


  33 in total

1.  Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations.

Authors:  Christopher L Bowlus; Chin-Shang Li; Tom H Karlsen; Benedicte A Lie; Carlo Selmi
Journal:  Liver Transpl       Date:  2010-11       Impact factor: 5.799

2.  Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis.

Authors:  J M Farrant; D G Doherty; P T Donaldson; R W Vaughan; K M Hayllar; K I Welsh; A L Eddleston; R Williams
Journal:  Hepatology       Date:  1992-08       Impact factor: 17.425

Review 3.  Update on primary sclerosing cholangitis.

Authors:  Tom H Karlsen; Erik Schrumpf; Kirsten M Boberg
Journal:  Dig Liver Dis       Date:  2010-02-20       Impact factor: 4.088

4.  Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.

Authors:  Peter K Gregersen; Roman Kosoy; Annette T Lee; Janine Lamb; Jon Sussman; David McKee; Kim R Simpfendorfer; Ritva Pirskanen-Matell; Frederik Piehl; Qiang Pan-Hammarstrom; Jan J G M Verschuuren; Maarten J Titulaer; Erik H Niks; Alexander Marx; Philipp Ströbel; Björn Tackenberg; Michael Pütz; Angelina Maniaol; Ahmed Elsais; Chantal Tallaksen; Hanne F Harbo; Benedicte A Lie; Soumya Raychaudhuri; Paul I W de Bakker; Arthur Melms; Henri-Jean Garchon; Nicholas Willcox; Lennart Hammarstrom; Michael F Seldin
Journal:  Ann Neurol       Date:  2012-10-10       Impact factor: 10.422

5.  Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.

Authors:  T H Karlsen; K M Boberg; M Vatn; A Bergquist; J Hampe; E Schrumpf; E Thorsby; S Schreiber; B A Lie
Journal:  Genes Immun       Date:  2007-02-15       Impact factor: 2.676

6.  Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data.

Authors:  Frank Dudbridge
Journal:  Hum Hered       Date:  2008-03-31       Impact factor: 0.444

7.  Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis.

Authors:  Annika Bergquist; Scott M Montgomery; Shahram Bahmanyar; Rolf Olsson; Ake Danielsson; Stefan Lindgren; Hanne Prytz; Rolf Hultcrantz; L A R S Lööf; Hanna Sandberg-Gertzén; Sven Almer; Johan Askling; Anna Ehlin; Anders Ekbom
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08       Impact factor: 11.382

8.  Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis.

Authors:  Peter T Donaldson; Suzanne Norris
Journal:  Autoimmunity       Date:  2002-12       Impact factor: 2.815

9.  Genetics of rheumatoid arthritis contributes to biology and drug discovery.

Authors:  Yukinori Okada; Di Wu; Gosia Trynka; Towfique Raj; Chikashi Terao; Katsunori Ikari; Yuta Kochi; Koichiro Ohmura; Akari Suzuki; Shinji Yoshida; Robert R Graham; Arun Manoharan; Ward Ortmann; Tushar Bhangale; Joshua C Denny; Robert J Carroll; Anne E Eyler; Jeffrey D Greenberg; Joel M Kremer; Dimitrios A Pappas; Lei Jiang; Jian Yin; Lingying Ye; Ding-Feng Su; Jian Yang; Gang Xie; Ed Keystone; Harm-Jan Westra; Tõnu Esko; Andres Metspalu; Xuezhong Zhou; Namrata Gupta; Daniel Mirel; Eli A Stahl; Dorothée Diogo; Jing Cui; Katherine Liao; Michael H Guo; Keiko Myouzen; Takahisa Kawaguchi; Marieke J H Coenen; Piet L C M van Riel; Mart A F J van de Laar; Henk-Jan Guchelaar; Tom W J Huizinga; Philippe Dieudé; Xavier Mariette; S Louis Bridges; Alexandra Zhernakova; Rene E M Toes; Paul P Tak; Corinne Miceli-Richard; So-Young Bang; Hye-Soon Lee; Javier Martin; Miguel A Gonzalez-Gay; Luis Rodriguez-Rodriguez; Solbritt Rantapää-Dahlqvist; Lisbeth Arlestig; Hyon K Choi; Yoichiro Kamatani; Pilar Galan; Mark Lathrop; Steve Eyre; John Bowes; Anne Barton; Niek de Vries; Larry W Moreland; Lindsey A Criswell; Elizabeth W Karlson; Atsuo Taniguchi; Ryo Yamada; Michiaki Kubo; Jun S Liu; Sang-Cheol Bae; Jane Worthington; Leonid Padyukov; Lars Klareskog; Peter K Gregersen; Soumya Raychaudhuri; Barbara E Stranger; Philip L De Jager; Lude Franke; Peter M Visscher; Matthew A Brown; Hisashi Yamanaka; Tsuneyo Mimori; Atsushi Takahashi; Huji Xu; Timothy W Behrens; Katherine A Siminovitch; Shigeki Momohara; Fumihiko Matsuda; Kazuhiko Yamamoto; Robert M Plenge
Journal:  Nature       Date:  2013-12-25       Impact factor: 49.962

10.  Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population.

Authors:  Sigrid Næss; Benedicte A Lie; Espen Melum; Marita Olsson; Johannes R Hov; Peter J P Croucher; Jochen Hampe; Erik Thorsby; Annika Bergquist; James A Traherne; Erik Schrumpf; Kirsten Muri Boberg; Stefan Schreiber; Andre Franke; Tom H Karlsen
Journal:  PLoS One       Date:  2014-12-18       Impact factor: 3.240

View more
  1 in total

Review 1.  Autoimmune Diseases of Digestive Organs-A Multidisciplinary Challenge: A Focus on Hepatopancreatobiliary Manifestation.

Authors:  Lumir Kunovsky; Petr Dite; Petr Jabandziev; Zdenek Kala; Jitka Vaculova; Tomas Andrasina; Matej Hrunka; Martina Bojkova; Jan Trna
Journal:  J Clin Med       Date:  2021-12-11       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.